Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Cardiac Rehabilitation

Presented by Quinn Pack, MD, MSc; Lillian Khor, MBBCh, MSc, Adam Oesterle, MD
Disclosures: None 

1.0 CEUs: AACVPR

Description: This session, recorded at the 2024 Annual Meeting, will discuss how the American College of Cardiology (ACC) and the American Heart Association (AHA) in conjunction with multiple other professional societies released two key guidelines in 2023 that have direct implications for patients attending cardiac rehabilitation. The first guideline discusses the optimal management of chronic coronary artery disease and includes dozens of recommendations for treatment, including the use of cardiac rehabilitation and decreasing sedentary time. This guideline also discusses the use of SGLT-2 inhibitors, dual anti-platelets, colchicine, dietary supplements, e-cigarettes, and introduces a more limited role for beta-blockers. The second guideline discusses classification and management of atrial fibrillation, including guidelines for risk-stratification, catheter ablation, anti-coagulation, and early rhythm control. It also emphasizes the role of lifestyle (weight loss, exercise, smoking cessation) in the prevention of recurrent atrial fibrillation. 

Learning Objective: 

1. Discuss the 2023 ACC/AHA guidelines for the Management of Patients with Chronic Coronary Artery disease.
2. Discuss the 2023 ACC/AHA guidelines for the Diagnosis and Management of Atrial Fibrillation.
3. Apply the new guidelines to clinical practice in cardiac rehabilitation

Viewing Window: 60 days from date of purchase